G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation
Authors:
- Marta Sánchez-SotoMSMarta Sánchez-Soto
- Noelia M. BoldizsarNBNoelia M. Boldizsar
- Kayla A. SchardienKSKayla A. Schardien
- Nora S. MadarasNMNora S. Madaras
- Blair K. A. WilletteBWBlair K. A. Willette
- Laura R. InbodyLILaura R. Inbody
- Christopher DasaroCDChristopher Dasaro
- Amy E. MoritzAMAmy E. Moritz
- Julia DrubeJDJulia Drube
- Raphael S. HaiderRHRaphael S. Haider
- R. Benjamin FreeRFR. Benjamin Free
- Carsten HoffmanCHCarsten Hoffman
Open Access
- 20 October 2023
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 13 (10) , 1552
Abstract
The D2 dopamine receptor (D2R) signals through both G proteins and β-arrestins to regulate important physiological processes, such as movement, reward circuitry, emotion, and cognition. β-arrestins are believed to interact with G protein-coupled receptors (GPCRs) at the phosphorylated C-terminal tail or intracellular loops. GPCR kinases (GRKs) are the primary drivers of GPCR phosphorylation, and for many receptors, receptor phosphorylation is indispensable for β-arrestin recruitment. However, GRK-mediated receptor phosphorylation is not required for β-arrestin recruitment to the D2R, and the role of GRKs in D2R–β-arrestin interactions remains largely unexplored. In this study, we used GRK knockout cells engineered using CRISPR-Cas9 technology to determine the extent to which β-arrestin recruitment to the D2R is GRK-dependent. Genetic elimination of all GRK expression decreased, but did not eliminate, agonist-stimulated β-arrestin recruitment to the D2R or its subsequent internalization. However, these processes were rescued upon the re-introduction of various GRK isoforms in the cells with GRK2/3 also enhancing dopamine potency. Further, treatment with compound 101, a pharmacological inhibitor of GRK2/3 isoforms, decreased β-arrestin recruitment and receptor internalization, highlighting the importance of this GRK subfamily for D2R–β-arrestin interactions. These results were recapitulated using a phosphorylation-deficient D2R mutant, emphasizing that GRKs can enhance β-arrestin recruitment and activation independently of receptor phosphorylation.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (ZIA NS002263, EFRE HSB 2018 0019, GrantCRC166 ReceptorLight project C02, MSP10)
- European Regional Development Fund (ZIA NS002263, EFRE HSB 2018 0019, GrantCRC166 ReceptorLight project C02, MSP10)
- the federal state of Thuringia, and the Deutsche Forschungsgemeinschaft (ZIA NS002263, EFRE HSB 2018 0019, GrantCRC166 ReceptorLight project C02, MSP10)
- University Hospital Jena IZKF (ZIA NS002263, EFRE HSB 2018 0019, GrantCRC166 ReceptorLight project C02, MSP10)
This publication has 53 references indexed in Scilit:
- The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatmentScientific Reports, 2012
- GRK2: multiple roles beyond G protein-coupled receptor desensitizationTrends in Pharmacological Sciences, 2012
- G protein-coupled receptor kinases: More than just kinases and not only for GPCRsPharmacology & Therapeutics, 2012
- Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 InhibitorsMolecular Pharmacology, 2011
- Fluorescent labeling of tetracysteine-tagged proteins in intact cellsNature Protocols, 2010
- The complex G protein‐coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targetsBritish Journal of Pharmacology, 2010
- G Protein-coupled Receptor Kinase-2 Constitutively Regulates D2 Dopamine Receptor Expression and Signaling Independently of Receptor PhosphorylationJournal of Biological Chemistry, 2009
- G Protein-coupled Receptor Kinase-mediated Phosphorylation Regulates Post-endocytic Trafficking of the D2 Dopamine ReceptorJournal of Biological Chemistry, 2009
- Arrestin3 mediates D2dopamine receptor internalizationSynapse, 2009
- Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 PathwayJournal of Biological Chemistry, 2007